Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Operating Margin: 2017-2025

Historic Operating Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to 13.74%.

  • Organogenesis Holdings' Operating Margin rose 832.00% to 13.74% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.80%, marking a year-over-year increase of 101.00%. This contributed to the annual value of -0.27% for FY2024, which is 316.00% down from last year.
  • According to the latest figures from Q3 2025, Organogenesis Holdings' Operating Margin is 13.74%, which was up 210.34% from -12.45% recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Operating Margin peaked at 19.15% during Q2 2021, and registered a low of -30.85% during Q1 2025.
  • In the last 3 years, Organogenesis Holdings' Operating Margin had a median value of -1.27% in 2023 and averaged -1.77%.
  • In the last 5 years, Organogenesis Holdings' Operating Margin skyrocketed by 3,674bps in 2021 and then tumbled by 2,735bps in 2025.
  • Quarterly analysis of 5 years shows Organogenesis Holdings' Operating Margin stood at 15.45% in 2021, then crashed by 790bps to 7.55% in 2022, then plummeted by 882bps to -1.27% in 2023, then surged by 934bps to 8.07% in 2024, then surged by 832bps to 13.74% in 2025.
  • Its last three reported values are 13.74% in Q3 2025, -12.45% for Q2 2025, and -30.85% during Q1 2025.